the effects of the gonadotropin-releasing hormone analog nafarelin on bone metabolism during treatment of premenopausal women for endometriosis were evaluated in two studies , both of which involved 6 months of medication followed by 6 months without medication .
C0064906
nafarelin
C0014175
endometriosis